Kevin Tang's Concentra swoops in on another struggling biotech, offering to buy Kezar
Concentra Biosciences, a shell company from Tang Capital, wants to buy another biotech that has found itself in a bind.
Kevin Tang’s shop told Kezar …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
